AbbVie has agreed to buy Apogee Therapeutics for about $10.9 billion in cash in a deal that bolsters the biopharmaceutical company’s immunology and inflammation portfolio.
Source link
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
Date:
More like thisRelated
Former Labor Secretary Oversaw a ‘Toxic, Intimidating’ Workplace, Report Finds
Internal watchdog concluded Lori Chavez-DeRemer had an inappropriate relationship...
PRCA announces 2026 Donita Barnes Lifetime Achievement Award finalists
COLORADO SPRINGS, Colo – The PRCA is proud to...
Rain and storm chances continue through the Labor Day weekend
A surge of monsoon moisture moving into New Mexico...